A study examining differences between men and women receiving immune or targeted cancer therapies found that women faced more adverse events than men, just as they face more adverse events with chemotherapy, according to the Journal of Clinical Oncology.

Yale researchers discovered that the epigenetic regulator gene cat eye syndrome chromosome region candidate 2, or CECR2, is responsible for driving breast cancer metastasis. 

News about potential negative consequences when prescribing metformin for cancer patients was Becker's most-read oncology story in February. 

Anatoly Nikolaev, MD, PhD, has joined the Cleveland Clinic Weston (Fla.) Maroone Cancer Center. 

The financial relief of medical crowdfunding is often accompanied by feelings of shame in asking for help, a study published in the Journal of Cancer Survivorship suggests.

Raleigh, N.C.-based UNC Rex Healthcare opened a new cancer center March 1. 

About 1 in 7 breast cancer cases are overdiagnosed, a study published March 1 in the Annals of Internal Medicine found.

The FDA approved carvykti, a new customized, cell-based treatment from Johnson & Johnson, for the treatment of multiple myeloma, Johnson & Johnson said Feb. 28.

Vanderbilt-Ingram Cancer Center in Nashville, Tenn., has selected Ben Ho Park, MD, PhD, as its new director. 

Yale Cancer Center named its annual Conclave awardees in honor of their outstanding contributions to cancer care and research. 

Metformin, a drug traditionally prescribed for diabetes but recently used in clinical settings as a cancer treatment, shows "great promise" but can have negative consequences in the treatment of some cancer types, researchers at the University of Waterloo in Canada said Feb. 28. 

Researchers at the University of California San Diego Health are the first in the county to employ high-intensity, focused ultrasound as a minimally invasive prostate cancer treatment, the system said Feb. 24.

Here are four announcements from the American Cancer Society reported by Becker's since Feb. 11:

The American Cancer Society awarded over $16 million in grants to establish cancer health equity research centers at minority-serving institutions of higher learning across the country, the organization said Feb. 24. 

Newport Beach, Calif.-based Hoag Memorial Hospital Presbyterian has selected Thomas Wang, MD, PhD, to serve as medical director of its melanoma/advanced skin cancer program. 

Los Angeles-based City of Hope was awarded a $4.9 million grant for its department of stem cell biology and regenerative medicine, the cancer research group said Feb. 22. 

Morristown, N.J.-based Atlantic Health System named Mohamad Cherry, MD, medical director of its hematology and cellular therapy programs, it said Feb. 23.

Yale Cancer Center is partnering with the National Brain Tumor Society to launch a flagship research initiative focused on DNA damage, the cancer center said Feb. 22.

The Barbara Ann Karmanos Cancer Institute in Detroit is collaborating with Lifeguard Health Networks to pilot a digital care platform for cancer patients. 

These six oncologists joined new practices or received new appointments over the last few weeks.